drugset / Trial / NCT00302770

Efficacy of Quetiapine in Generalised Social Anxiety Disorder

NCT00302770

Phase 3 Terminated 50 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial will explore the efficacy of quetiapine in Social Anxiety Disorder, generalized type. The following elements of response will be tested: number of responders to treatment, time to response, effect size as measured with the LSAS

Timeline

Start
2006-06
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule

Indications